Tue, Sep 16, 2014, 10:08 AM EDT - U.S. Markets close in 5 hrs 52 mins

Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • bioimmunomabman bioimmunomabman Oct 18, 2013 9:38 AM Flag

    Good post on the IV board regarding Kadcyla use

    According to interviews with Oncologists, Kad is already widely used in 2nd and 3rd line.

    IMGN valuation is $1.5BB SGEN is $5BB. That seems out of line considering the 10 compounds IMGN has, or shares. Lots of new clinical info is expected over the next 12 months. 289 might be too new/early stage for clinical data in 2014, but I think IMGN and partners will have info on just about everything else over the next 12 months.

 
IMGN
10.990.00(0.00%)10:06 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.